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More than 50% of spontaneous abortions (SAs) have abnormal chromosomes; the most common abnormalities
are trisomy, sex chromosome monosomy, and polyploidy. Conventional cytogenetic analysis of SAs depends on
tissue culturing and is associated with a significant tissue culture failure rate and contamination by maternally
derived cells. Comparative genomic hybridization (CGH), in combination with flow cytometry (FCM), can detect
numerical and unbalanced structural chromosomal abnormalities associated with SAs while avoiding the technical
problems associated with tissue culture. Routine cytogenetic and CGH analysis was performed independently on
tissue from 301 SAs. Samples shown to be chromosomally balanced by CGH were analyzed by FCM to determine
ploidy. Of 253 samples successfully analyzed by both approaches, there was an absolute correlation of results in
235 (92.8%). Of the 18 cases with discrepancies between cytogenetic and CGH/FCM results, an explanation could
be found in 17. Twelve samples produced a 46,XX karyotype by cytogenetics, whereas CGH/FCM demonstrated
aneuploidy/polyploidy or a male genome, indicating maternal contamination of the tissue cultures. In two cases,
where tetraploidy was demonstrated by cytogenetics and diploidy by FCM, tissue culture artifact is implied. In
three cases, CGH demonstrated an aneuploidy, and cytogenetics demonstrated hypertriploidy. In one unexplainable
case, aneuploidy demonstrated by CGH could not be detected by repeat CGH analysis, conventional cytogenetic,
or FISH analysis. These results demonstrate that CGH supplemented with FCM can readily identify chromosomal
abnormalities associated with SAs and, by avoiding maternal contamination and tissue culture artifacts, can do so
with a lower failure rate and more accuracy than conventional cytogenetic analysis.
Introduction
More than 50% of all spontaneous abortions (SAs) have
abnormal chromosomes, mainly numerical chromoso-
mal defects such as trisomy of autosomes (29%), mon-
osomy X (10%), polyploidy (10%), and mosaicism or
structural abnormalities (2%) (Hassold 1986; Kalousek
et al. 1993). Cytogenetic analysis of an aborted concep-
tus provides valuable information regarding the recur-
rence risk and possible therapies for couples experienc-
ing recurrent SAs. Cytogenetic studies of SAs rely on
obtaining viable tissue, establishing primary cultures,
and harvesting metaphase chromosomes for analysis.
The methodology of cell culture and analysis of chro-
mosomes is well established and has been accepted as a
clinical diagnostic technique for the past 4 decades (Roo-
ney and Czepulkowski 1997). It is well recognized that
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this approach has limitations—specifically, the relatively
high rates of tissue culture failure (10%–40%) and se-
lective overgrowth of maternally derived cells such that
the finding of a normal female karyotype may not be
representative of the conceptus (Bell et al. 1999).
Comparative genomic hybridization (CGH) is a tech-
nique that offers a molecular approach to cytogenetic
analysis and allows the entire genotype to be screened
in a single hybridization (Kallioniemi et al. 1992). The
CGH technique involves the simultaneous hybridization
of genomic test and reference DNAs, each labeled with
a different fluorochrome, to normal target metaphase
chromosomes. By comparing the relative intensities of
the two fluorochromes along the length of each target
chromosome, one can detect variations in DNA copy
number between the test and reference genomes. CGH
can readily identify numerical and unbalanced struc-
tural chromosomal abnormalities. It has been success-
fully applied to the evaluation of postnatal cases in
which traditional cytogenetic analysis yielded ambigu-
ous results (Levy et al. 1998). To date, the application
of CGH to the analysis of conceptuses has been limited
(Bryndorf et al. 1995; Atkins et al. 1997; Daniely 1998),
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because of the fact that, although CGH can readily de-
tect chromosomal imbalances, it is unable to differen-
tiate between diploid, triploid, and tetraploid states.
Flow cytometry (FCM) can be used for the quanti-
tative determination of cellular DNA content. FCM has
been used extensively for ploidy analysis of molar preg-
nancies and has gained widespread popularity because
it is easy to perform, rapid, accurate, and inexpensive
(Berezowsky et al. 1995). By combining CGH analysis
with FCM, it is feasible to screen a test DNA for chro-
mosomal imbalances with CGH and, when no imbal-
ance is detected, to determine the ploidy status with
FCM. With this approach, it is possible to detect vir-
tually all numerical and unbalanced structural abnor-
malities that are associated with SAs. In the present
report, we describe the first controlled study of SAs,
comparing conventional cytogenetic analysis to a novel
approach that uses CGH analysis supplemented with
FCM.
Material and Methods
Study Population
The study population includes products of 301 first-
and second-trimester SAs which were examined at the
embryofetopathology laboratory of the British Colum-
bia (B.C.) Children’s and Women’s Hospital. The ma-
jority of samples were obtained from abortions in which
there was a maternal history of advanced maternal age
or repeated pregnancy loss or from those with pheno-
typic abnormalities of the embryo or fetus. The samples
were taken from amniotic membrane and/or chorionic
sac and varied in size from 10–100 mg. All samples were
submitted for routine cytogenetic analysis to the clinical
cytogenetics laboratory of the B.C. Children’s and
Women’s Hospital, with duplicate tissue samples being
submitted for CGH/FCM analysis.
Tissue Preparation and DNA Isolation
All tissues were grossly examined, freed of any ma-
ternal decidua, and washed clean of blood. High–
molecular-weight DNA was isolated from the tissue by
the high salt extraction method described by Miller et
al. (1988). After extraction, DNA was precipitated in
two volumes of cold ethanol and dissolved in 10 mM
Tris, 0.2 mM EDTA, pH 8.
DNA Labeling and CGH Technique
Labeling and hybridization protocols were performed
as described by Lestou et al. (1999). Test DNA was
labeled with FITC-12-dUTP and the 46,XX reference
DNA with TRITC-6-dUTP.
Preparation of Metaphase Chromosomes
Diploid metaphase spreads were obtained from pe-
ripheral blood lymphocyte cultures of normal male do-
nors by use of standard protocols. Male target meta-
phases were used to provide copy number informa-
tion about all chromosomes, including Y. Slide prepa-
ration was optimized to minimize residual cytoplasm
and to generate well-spread metaphases of 350–400
band-length resolution.
Digital Image Analysis
Image capture and analysis were performed by means
of a Zeiss Axioplan epifluorescence microscope with se-
lective filters, a COHU charge coupled device camera,
and Perceptive Scientific Instruments POWERGENE
software. The criteria used for assessing the quality of
CGH preparations are described by Kallioniemi et al.
(1994). A minimum of four high-quality metaphase
spreads were analyzed from each hybridization, and av-
erage red-to-green fluorescence intensity ratio profiles
were generated for each chromosome.
Interpretation of CGH Ratio Profiles
A shift in the average red-to-green ratio value (plus 2
SD) above 1.1 was considered an indication of increased
copy number (i.e., trisomy), and any shifts below 0.9
were considered an indication of reduced copy number
(i.e., monosomy). Heterochromatic regions near the cen-
tromeres of chromosomes 1, 9, and 16, the q arm of the
Y chromosome, and the satellite regions of the acrocen-
tric chromosomes were not considered in our interpre-
tation of the CGH profile analysis, because these regions
are polymorphic and are largely suppressed by the Cot-
1 DNA. CGH ratio profiles for chromosomes 1pter, 16p,
19, and 22 were interpreted with caution, because these
regions are subject to labeling artifacts that can result
in variations in the ratio profiles (Kallioniemi et al. 1994;
Lestou et al. 1999). Although it may be theoretically
possible to differentiate between a 46,XY genotype and
a 69,XXY genotype by the degree of shift in X-chro-
mosome profile (0.5 vs. 0.66, respectively), in light of
the inherent variability of CGH profiles and the possi-
bility of maternal contamination of the test DNA, for
the purposes of this study we have not used CGH profiles
to determine ploidy.
FCM Analysis
All samples shown by CGH analysis to be balanced
were subsequently sent for FCM analysis to the analytic
cytology laboratory at the British Columbia Cancer
Agency. Nuclear suspensions were prepared from for-
malin-fixed, paraffin-embedded chorionic villous tissue,
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Table 1
Summary of 253 Cases Analyzed by both Conventional
Cytogenetic and CGH/FCM Analyses
Finding Cytogenetic Analysis CGH/FCM Analysis
Diploidy 98 (38.7) 92 (36.4)
Polyploidy 25 (9.9) 21 (8.3)
Aneuploidy 111 (43.9) 121 (47.8)
Monosomy X 12 (4.7) 12 (4.7)
Structural imbalance 7 (2.8) 7 (2.8)
NOTE.—Numbers in parentheses are percentages.
as described by Hedley et al. (1983). FCM analysis was
performed on a Beckman/Coulter Epic Elite Flow cy-
tometer. Data were analyzed with Beckman/Coulter
ELITE software and MULTICYCLE software (Phoenix
Flow Systems).
FISH Analysis
FISH was performed on trophoblast suspension by
means of unique sequence and a-satellite DNA probes
(Oncor), as described by Henderson et al. (1996). At
least 100 interphase nuclei were analyzed per sample.
Sex Determination
Sex determination by the use of primers that flank a
region of the Y chromosome–specific SRY gene (BioCan
Scientific/GENOSYS) was performed on four samples
for which maternal contamination of the tissue cultures
was suspected and for which CGH analysis indicated a
male genome. PCR amplification was done under stan-
dard conditions, and the resulting male-specific 239-bp
band was visualized on a 1% agarose gel.
Results
A total of 301 samples were submitted for both con-
ventional cytogenetic and CGH/FCM analysis. Thirty-
five samples failed to produce metaphase chromosomes
of sufficient quality for cytogenetic analysis. Extraction
of DNA from seven samples did not yield adequate DNA
for CGH analysis. In three samples, both tissue culture
and DNA extraction failed. Thirteen samples that dem-
onstrated a balanced CGH profile could not be subse-
quently analyzed by FCM, because no formalin-fixed,
paraffin-embedded chorionic villous tissue was avail-
able, and four of the same samples also failed tissue
culture. Therefore, 48 cases could not be analyzed by
one or more method(s).
We successfully analyzed 253 samples by both con-
ventional cytogenetic and CGH/FCM analyses (table 1).
Identical findings were obtained by the two approaches
for 235 cases, a 92.8% correlation rate. Discrepancies
between the cytogenetic and CGH/FCM results oc-
curred in 18 samples (table 2). Twelve samples (4.7%)
with a 46,XX karyotype by cytogenetic analysis dem-
onstrated aneuploidy/polyploidy or a diploid male ge-
nome by CGH/FCM, thereby suggesting maternal con-
tamination of the tissue cultures. In addition, sex
determination of cases 3, 4, 7, and 10 (table 2) dem-
onstrated a PCR product for the SRY marker, which
indicates the presence of a Y chromosome. FISH anal-
ysis, by means of a chromosome 22–specific DNA probe
of trophoblast from case 6, confirmed the trisomy 22
detected by CGH analysis. In two cases (13 and 14) in
which tetraploidy was demonstrated by cytogenetics
and diploidy by FCM, tissue culture artifact is implied.
Additional FISH analysis of case 14, by means of a-
satellite DNA probes for chromosomes 7 and 2, dem-
onstrated only two copies of each chromosome pair. In
three cases, a chromosomal imbalance was demon-
strated by CGH, and, therefore, the samples were not
initially analyzed by FCM. Cytogenetic analysis of these
three samples demonstrated triploidy in combination
with the same chromosomal imbalances that were de-
tected by CGH. Subsequent FCM analysis confirmed
polyploidy in all three samples. In one final case, CGH
analysis demonstrated aneuploidy that was not detected
on repeat testing or by conventional cytogenetic analysis
and subsequent FISH analysis.
Discussion
Our aim was to determine whether the CGH technique
is as effective as traditional cytogenetics for analysis of
SAs. As anticipated, the rate of failure for CGH (2%)
was lower than that for cytogenetic analysis (12%). We
found that only 7 of 301 samples were too small for
extraction of adequate DNA for CGH analysis, as com-
pared with 35 of 301 samples that failed to grow or
produce sufficient metaphase chromosomes for conven-
tional analysis. This finding indicates that the collection
of samples for CGH analysis is easier than for conven-
tional methods, because the main limiting factor is the
size of the sample. We found that with experience, when
20 mg of the tissue was provided, CGH results could be
guaranteed. The fact that, among 35 tissue culture fail-
ures, CGH analysis provided results in 32 cases repre-
sents a significant improvement from the reproductive
counseling perspective. Among these 32 cases, the di-
agnosis of aneuploidy was made in 20 and balanced
karyotype in 12.
Maternal contamination represented the main ex-
plainable discrepancy between conventional cytogenetic
analysis and CGH analysis. In 12 women diagnosed as
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Table 2
Summary of 18 Cases with Discrepancy between Results Obtained by Conventional Cytogenetic and CGH/FCM Analyses
Case CGH Result FCM Cytogenetic Karyotype
Additional
Analysis Interpretation
1 XX, gain for 19 ) 46,XX NA Maternal contamination
2 XX, gain for 3 and 10 ) 46,XX NA Maternal contamination
3 XY, gain for 21 ) 46,XX SRY1ve Maternal contamination
4 XY, gain for 4q ) 46,XX SRY1ve Maternal contamination
5 XX, gain for 15 ) 46,XX NA Maternal contamination
6 XX, gain for 22 ) 46,XX FISH: trisomy
(D22S75)
Maternal contamination
7 XY, balanced Diploid 46,XX SRY1ve Maternal contamination
8 XX, gain for 22 ) 46,XX NA Maternal contamination
9 XX, gain for 22 ) 46,XX NA Maternal contamination
10 XY, gain for 20 ) 46,XX SRY1ve Maternal contamination
11 XX, balanced Tetraploid 46,XX NA Maternal contamination
12 XX, balanced Tetraploid 46,XX NA Maternal contamination
13 XY, balanced Diploid 92,XXYY NA Tissue culture artifact
14 XY, balanced Diploid 92,XXYY FISH: disomy
D7Z1/2 and D2Z1
Tissue culture artifact
15 XY, gain for 8, loss for 18 Triploid 69,XXY,18,218 NA Hypertriploidy
16 XX, gain for 14 Triploid 70,XXX,114 NA Hypertriploidy
17 XY, gain for 4 Triploid 70,XXY,14 NA Hypertriploidy
18 XY, gain for 18 ) 92,XXYY,21,1idic(1)(p31) FISH: tetraploidy
D18Z1 and D8Z1
Sample mislabeling
NOTE.—Ellipses points ()) indicate that FCM was not performed because CGH analysis indicated an unbalanced karyotype.
SRY1ve indicates that microsatellite analysis demonstrated presence of Y chromosome–specific marker. NA indicates that insufficient
tissue was available for additional analysis.
having a normal female karyotype by traditional cy-
togenetics, a male karyotype with aneuploidy was de-
tected three times, a normal male karyotype once, a
female karyotype with aneuploidy six times, and tetra-
ploidy twice. The detection of aneuploidy is especially
important for reproductive counseling, because the de-
termination of a normal karyotype is usually interpreted
as a poor prognostic sign and leads to more-intensive
investigation of the cause of pregnancy loss. In an effort
to confirm our interpretation of maternal contamina-
tion, additional analyses were performed when possible.
Sex determination by the use of SRY-specific sequences
was performed on four cases that demonstrated a male
karyotype by CGH analysis. All four cases showed the
presence of the Y chromosome–specific marker. FISH
analysis by means of chromosome 22–specific DNA
probes confirmed the trisomy 22 diagnosed by CGH.
Together, these additional analyses support our inter-
pretation of maternal contamination.
It was interesting to note that maternal contamination
is not the only tissue culture artifact observed in cyto-
genetic analysis of SAs. In two separate cases, we had
traditional cytogenetic diagnosis of tetraploidy, whereas
CGH/FCM demonstrated diploidy. High levels of tetra-
ploidy or even complete tetraploidy have elsewhere been
described in cultured amniotic fluid in pregnancies with
a normal diploid fetus (Kohn and Robinson 1970). Ad-
ditional tissue was available for FISH analysis of one
of our cases, and the results showed only two copies of
each chromosome pair tested.
Hypertriploidy detected by traditional cytogenetic
analysis was interpreted from CGH results as aneuploi-
dy. When the study was finalized and the results of
traditional analysis and CGH compared, it was obvious
that three cases with hypertriploidy were interpreted on
CGH as aneuploidy and were not submitted for FCM
analysis. Retrospective FCM analysis has confirmed the
presence of triploidy. From a reproductive-counseling
point of view, the knowledge of existing aneuploidy and
the lack of knowledge about the triploidy does not
change the management of the future pregnancy.
Only human error (i.e., sample mislabeling) can
explain one discrepancy, in which the original CGH
analysis showed unquestionable trisomy 18 in a male
karyotype. Traditional cytogenetic analysis showed
tetraploidy, which was confirmed by FISH analysis
(table 2). After having repeated the CGH analysis
several times, we could demonstrate only a balanced
male karyotype.
The advantages of CGH analysis of SAs are broader
than diagnostic accuracy. Technically, CGH analysis al-
lows collected tissues to be stored in the freezer and
batching of DNA extraction, labeling, and hybridiza-
tion, thereby increasing technical efficiency. Because one
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technologist can process twice as many samples per unit
of time, the entire procedure is more cost-effective than
traditional cytogenetic analysis combined with tissue
culture. An additional FCM analysis is required for all
diploid samples, however, because the distinction be-
tween polyploidy and diploidy is an important one for
reproductive counseling. In the future, we plan to per-
form FCM on a portion of frozen tissue sample set aside
prior to DNA extraction, rather than on formaldehyde-
fixed and paraffin-embedded placental tissue.
Of critical importance to the accuracy of the analysis
is the correct identification of the aborted tissues, such
that maternal tissues are not used for analysis. Although
a DNA-based approach avoids the problems associated
with tissue culturing, the integrity of the analysis de-
pends on extracting DNA from an appropriate tissue.
Although CGH has been shown to be capable of de-
tecting placental mosaicism as low as 32% (Lomax et
al. 1998), because of the inherent variability of the tech-
nique (Lestou et al. 1999), the presence of high levels
(60%–70%) of maternal cells in a tissue sample may
render CGH analysis ineffective in the determination of
fetal aneuploidy or a male fetus. Proper identification
and separation of maternal and fetal/placental tissues is
essential if this approach is to be effective.
It would be of interest to repeat cytogenetic studies
of SAs with elimination of culture failure, culture ar-
tifact, and maternal contamination. Some classic articles
in this field do not mention the rate of culture failure
(Bouie´ et al. 1976), whereas others describe failure rates
of 47% (Creasy et al. 1976) and slightly less than one-
third (Kajii et al. 1980). If our CGH results from cases
with tissue culture failure represent a general trend, then
about two-thirds of the failed specimens would have
shown chromosomal aneuploidy. Further, by eliminat-
ing maternal contamination, the rate of chromosomal
aneuploidy (trisomy) would be, in general, higher than
is currently accepted. The repetition of earlier studies
would allow even greater accuracy in karyotype-phe-
notype correlation, because of the availability of ultra-
sound morphology of missed abortions.
In summary, the CGH/FCM analysis provided ac-
curate information on the chromosomal complement of
SAs in 99.7% of analyzable cases. In only one case (case
18), the result obtained by CGH could not be confirmed
in repeated CGH experiments or explained by cytoge-
netic or FCM findings. It was finally attributed to hu-
man error. We do, however, believe that the advantages
of CGH overcome the difficulties we experienced in ex-
plaining this one case. CGH/FCM analysis not only
identified cases with maternal contamination and tissue
culture artifacts that provided misleading clinical in-
formation but also revealed, for the first time, the chro-
mosomal composition of tissues from SAs that failed to
grow in culture. Future extensive CGH analysis of tis-
sue-culture failures will provide additional insight and
may even change our knowledge on the frequencies of
chromosomal abnormalities in SAs.
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